Biography

Prof. Pierre Sirois
Laval University, Canada

Professor


Email: [email protected]


Qualifications

1975  Ph.D. (Pharmacology), University of Sherbrook
1972  M.Sc. (Pharmacology), University of Sherbrooke
1971  B.Sc. (Biology), University of Sherbrooke

1967  B.A., Laval University


Publications (Selected)

  1. Li Xiao, Juan-Sebastian Saldivar, Cuilan Zhou, Chengli Chen, Jia Zhang, Pierre Sirois, Kai Li (2009)  The updated concept of genome and its implications in biotechnological research and molecular diagnostics.   Mol Biotechnol 41: 2. 152-156 Feb
  2. L Xiao, J Zhang, Y F Yin, C L Chen, Kai Li, A Chang, P Sirois (2008)  Molecular diagnosis of HIV and relevant novel technologies in mutation analysis.   Biotechnol Adv 26: 5. 389-397 Sep/Oct
  3. Martin Richter, Solange Cloutier, Pierre Sirois (2007)  Endothelin, PAF and thromboxane A2 in allergic pulmonary hyperreactivity in mice.   Prostaglandins Leukot Essent Fatty Acids 76: 5. 299-308 May
  4. Monica C Toffoli, Bichoy H Gabra, Catarina F P Teixeira, Pierre Sirois, Sonia Jancar (2007)  Endothelins mediate neutrophil activation, ProMMP-9 release and endothelial cell detachment.   Inflammation 30: 1-2. 28-37 Apr
  5. Quan Yang, Bruno Battistini, Stéphane Pelletier, Pierre Sirois (2007)  Inhibition of basal and stimulated release of endothelin-1 from guinea pig tracheal epithelial cells in culture by beta 2-adrenoceptor agonists and cyclic AMP enhancers. Inflammation 30: 5. 136-147 Oct
  6. Richardt G Landgraf, Daniela F Nossi, Pierre Sirois, Sonia Jancar (2007) Prostaglandins, leukotrienes and PAF selectively modulate lymphocyte subset and eosinophil infiltration into the airways in a murine model of asthma. Prostaglandins Leukot Essent Fatty Acids 77: 3-4. 163-172 Oct/Nov
  7. Jia Zhang, Y O Wu, Li Xiao, Kai Li, L L Chen, P Sirois (2007)  Therapeutic potential of RNA interference against cellular targets of HIV infection.   Mol Biotechnol 37: 3. 225-236 Nov
  8. P Daull, R Lepage, O Benrezzak, J Cayer, M Beaudoin, K Belleville, A Blouin, P Sirois, F Nantel, A Y Jeng, B Battistini (2006)  The first preclinical pharmacotoxicological safety assessment of CGS 35601, a triple vasopeptidase inhibitor, in chronically instrumented, conscious, and unrestrained spontaneously hypertensive rats.   Drug Chem Toxicol 29: 2. 183-202
  9. P Daull, A Blouin, M Beaudoin, S Gadbois, K Belleville, J Cayer, N Berthiaume, P Sirois, F Nantel, A Y Jeng, B Battistini (2006)  The hemodynamic and metabolic profiles of Zucker diabetic fatty rats treated with a single molecule triple vasopeptidase inhibitor, CGS 35601.   Exp Biol Med (Maywood) 231: 6. 824-829 Jun
  10. P Daull, A Blouin, K Belleville, M Beaudoin, D Arsenault, H Leonard, P Sirois, F Nantel, A Y Jeng, B Battistini (2006)  Triple VPI CGS 35601 reduces high blood pressure in low-renin, high-salt Dahl salt-sensitive rats.   Exp Biol Med (Maywood) 231: 6. 830-833 Jun


Profile Details

https://www.linkedin.com/in/pierre-sirois-8990822b/?originalSubdomain=ca

http://publicationslist.org/pierre.sirois

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top